Shares in AbbVie (ABBV -4.58%) rose in the company's first day of trading on the New York Stock Exchange Wednesday, NYSE data shows. The stock advanced from an opening price of $34.92 to $35.12 at market close.
Shortly before the debut, officials from the firm rang the NYSE's opening bell in the exchange's first trading day of this year.
AbbVie is a publicly traded spinoff of health care concern Abbott Laboratories (ABT 0.63%). It specializes in the manufacture and sale of branded drugs, particularly the state-of-the-art, anti-inflammatory medication HUMIRA. According to a press release the company issued to mark its stock market debut, it has an estimated $18 billion in annual revenues.
Click here to watch a video of Fool analysts discussing the key issues that new AbbVie shareholders have to understand.
